Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
ATP-binding cassette (ABC) transporters mediate the ATP-driven translocation of structurally
and mechanistically distinct substrates against steep concentration gradients. Among the …
and mechanistically distinct substrates against steep concentration gradients. Among the …
FGF/FGFR-dependent molecular mechanisms underlying anti-cancer drug resistance
J Szymczyk, KD Sluzalska, I Materla, L Opalinski… - Cancers, 2021 - mdpi.com
Simple Summary Deregulation of the FGF/FGFR axis is associated with many types of
cancer and contributes to the development of chemoresistance, limiting the effectiveness of …
cancer and contributes to the development of chemoresistance, limiting the effectiveness of …
System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma
C Yan, Y Niu, F Li, W Zhao, L Ma - Journal of translational medicine, 2022 - Springer
Background Pancreatic adenocarcinoma (PAAD) is one of the most common malignant
tumors of the digestive tract. Pyroptosis is a newly discovered programmed cell death that …
tumors of the digestive tract. Pyroptosis is a newly discovered programmed cell death that …
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
S Wu, L Fu - Molecular cancer, 2018 - Springer
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
Abstract Multidrug resistance protein 7 (MRP7), also known as ATP-binding cassette (ABC)
transporter subfamily C10 (ABCC10), is an ABC transporter that was first identified in 2001 …
transporter subfamily C10 (ABCC10), is an ABC transporter that was first identified in 2001 …
Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges
X Chen, Y Huang, B Chen, H Liu, Y Cai… - European Journal of …, 2024 - Elsevier
Recently, FGFR4 has become a hot target for the treatment of cancer owing to its important
role in cellular physiological processes. FGFR4 has been validated to be closely related to …
role in cellular physiological processes. FGFR4 has been validated to be closely related to …
Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance
Tyrosine kinases (TKs) play an important role in pathways that regulate cancer cell
proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been …
proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been …
Infigratinib (BGJ 398), a pan-FGFR inhibitor, targets P-glycoprotein and increases chemotherapeutic-induced mortality of multidrug-resistant tumor cells
S Boichuk, P Dunaev, I Mustafin, S Mani, K Syuzov… - Biomedicines, 2022 - mdpi.com
The microtubule-targeting agents (MTAs) are well-known chemotherapeutic agents
commonly used for therapy of a broad spectrum of human malignancies, exhibiting epithelial …
commonly used for therapy of a broad spectrum of human malignancies, exhibiting epithelial …
Exploring the structural and functional diversity among FGF signals: A comparative study of human, mouse, and xenopus FGF ligands in embryonic development and …
Fibroblast growth factors (FGFs) encode a large family of growth factor proteins that activate
several intracellular signaling pathways to control diverse physiological functions. The …
several intracellular signaling pathways to control diverse physiological functions. The …
Drug resistance: from bacteria to cancer
The phenomenon of drug resistance has been a hindrance to therapeutic medicine since
the late 1940s. There is a plethora of factors and mechanisms contributing to progression of …
the late 1940s. There is a plethora of factors and mechanisms contributing to progression of …